• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重叠指数作为评估早期 Tau PET 信号可靠性的一种手段。

The Overlap Index as a Means of Evaluating Early Tau PET Signal Reliability.

机构信息

Department of Radiology, Rochester, Minnesota;

Department of Radiology, Rochester, Minnesota.

出版信息

J Nucl Med. 2022 Nov;63(11):1748-1753. doi: 10.2967/jnumed.121.263136. Epub 2022 Mar 17.

DOI:10.2967/jnumed.121.263136
PMID:35301239
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9635680/
Abstract

In tau PET, a reliable method to detect early tau accumulation in the brain is crucial. Noise, artifacts, and off-target uptake impede detection of subtle true-positive ligand binding. We hypothesize that identifying voxels with stable activity over time can enhance detection of true-positive tau. In total, 339 participants in the clinical spectrum ranging from clinically unimpaired to Alzheimer disease dementia underwent at least 2 serial tau PET scans with flortaucipir. The overlap index (OI) method was proposed to detect spatially identical, voxelwise SUV ratio (SUVR) elevation when seen sequentially in serial tau PET scans. The association of OI with tau accumulation, clinical diagnosis, and cognitive findings was evaluated. OI showed good dynamic range in the low-SUVR window. Only OI was able to identify subgroups with increasing tau PET signal in low-SUVR meta-region-of-interest (ROI) groups. OI showed improved association with early clinical disease progression and cognitive scores versus meta-ROI SUVR measures. OI was more sensitive to tau signal elevation and longitudinal change than standard ROI measures, suggesting it is a more sensitive method for detecting early, subtle deposition of neurofibrillary tangles.

摘要

在 tau PET 中,可靠的方法来检测大脑中早期 tau 的积累至关重要。噪声、伪影和非靶标摄取会阻碍对微妙的真正阳性配体结合的检测。我们假设,确定随时间稳定活动的体素可以增强对真正阳性 tau 的检测。共有 339 名参与者在临床范围内,从临床无症状到阿尔茨海默病痴呆,接受了至少 2 次 flortaucipir 的 tau PET 扫描。提出了重叠指数 (OI) 方法来检测当在连续 tau PET 扫描中依次看到时空间相同的体素 SUV 比 (SUVR) 升高。评估了 OI 与 tau 积累、临床诊断和认知发现的相关性。OI 在低 SUVR 窗口中显示出良好的动态范围。只有 OI 能够识别在低 SUVR 元感兴趣区 (ROI) 组中tau PET 信号增加的亚组。与 meta-ROI SUVR 测量相比,OI 与早期临床疾病进展和认知评分的相关性更好。OI 比标准 ROI 测量更能敏感地检测到 tau 信号的升高和纵向变化,表明它是一种更敏感的方法,用于检测早期、微妙的神经纤维缠结沉积。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da60/9635680/61d7ca6a0c8c/jnumed.121.263136f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da60/9635680/cb2dc03ecca7/jnumed.121.263136absf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da60/9635680/3f4c60ff6181/jnumed.121.263136f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da60/9635680/70dc8f17d68f/jnumed.121.263136f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da60/9635680/fb7686d72ce2/jnumed.121.263136f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da60/9635680/1f5fb7bf5115/jnumed.121.263136f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da60/9635680/e34945c59f32/jnumed.121.263136f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da60/9635680/61d7ca6a0c8c/jnumed.121.263136f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da60/9635680/cb2dc03ecca7/jnumed.121.263136absf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da60/9635680/3f4c60ff6181/jnumed.121.263136f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da60/9635680/70dc8f17d68f/jnumed.121.263136f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da60/9635680/fb7686d72ce2/jnumed.121.263136f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da60/9635680/1f5fb7bf5115/jnumed.121.263136f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da60/9635680/e34945c59f32/jnumed.121.263136f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da60/9635680/61d7ca6a0c8c/jnumed.121.263136f6.jpg

相似文献

1
The Overlap Index as a Means of Evaluating Early Tau PET Signal Reliability.重叠指数作为评估早期 Tau PET 信号可靠性的一种手段。
J Nucl Med. 2022 Nov;63(11):1748-1753. doi: 10.2967/jnumed.121.263136. Epub 2022 Mar 17.
2
Test-Retest Reproducibility for the Tau PET Imaging Agent Flortaucipir F 18.Flortaucipir F 18 Tau PET 显像剂的测试-重测可重复性。
J Nucl Med. 2018 Jun;59(6):937-943. doi: 10.2967/jnumed.117.200691. Epub 2017 Dec 28.
3
Longitudinal 18F-MK-6240 tau tangles accumulation follows Braak stages.18F-MK-6240 tau 缠结的纵向积累遵循 Braak 分期。
Brain. 2021 Dec 16;144(11):3517-3528. doi: 10.1093/brain/awab248.
4
Compensating for choroid plexus based off-target signal in the hippocampus using F-flortaucipir PET.使用 F-flortaucipir PET 补偿海马体中的脉络丛基于靶点的信号。
Neuroimage. 2020 Nov 1;221:117193. doi: 10.1016/j.neuroimage.2020.117193. Epub 2020 Jul 22.
5
A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer's disease dementia.多中心纵向研究氟替卡滨(18F)在正常衰老、轻度认知障碍和阿尔茨海默病痴呆中的作用。
Brain. 2019 Jun 1;142(6):1723-1735. doi: 10.1093/brain/awz090.
6
Associations between quantitative [F]flortaucipir tau PET and atrophy across the Alzheimer's disease spectrum.定量 [F]flortaucipir tau PET 与阿尔茨海默病谱中萎缩的相关性。
Alzheimers Res Ther. 2019 Jul 4;11(1):60. doi: 10.1186/s13195-019-0510-3.
7
Sex modulates the ApoE ε4 effect on brain tau deposition measured by F-AV-1451 PET in individuals with mild cognitive impairment.性别调节载脂蛋白 E ε4 对轻度认知障碍个体脑 Tau 沉积的影响,通过 F-AV-1451 PET 进行测量。
Theranostics. 2019 Jul 9;9(17):4959-4970. doi: 10.7150/thno.35366. eCollection 2019.
8
Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages.候选 tau PET 配体 18F-AV-1451 的区域特征再现了 Braak 组织病理学分期的关键特征。
Brain. 2016 May;139(Pt 5):1539-50. doi: 10.1093/brain/aww023. Epub 2016 Mar 2.
9
Relationships Between Cognition and Neuropathological Tau in Alzheimer's Disease Assessed by 18F Flortaucipir PET.阿尔茨海默病中 18F 氟脱氧酪氨酸正电子发射断层扫描(18F Flortaucipir PET)评估的认知与神经病理 tau 之间的关系。
J Alzheimers Dis. 2021;80(3):1091-1104. doi: 10.3233/JAD-200808.
10
Biomarker-Based Prediction of Longitudinal Tau Positron Emission Tomography in Alzheimer Disease.基于生物标志物的阿尔茨海默病纵向 Tau 正电子发射断层扫描预测。
JAMA Neurol. 2022 Feb 1;79(2):149-158. doi: 10.1001/jamaneurol.2021.4654.

引用本文的文献

1
Synthesizing images of tau pathology from cross-modal neuroimaging using deep learning.利用深度学习从跨模态神经影像学合成 tau 病理学图像。
Brain. 2024 Mar 1;147(3):980-995. doi: 10.1093/brain/awad346.
2
Stricker Learning Span criterion validity: a remote self-administered multi-device compatible digital word list memory measure shows similar ability to differentiate amyloid and tau PET-defined biomarker groups as in-person Auditory Verbal Learning Test.斯特里克尔学习跨度标准效度:远程自我管理的多设备兼容数字单词列表记忆测试在区分淀粉样蛋白和 tau PET 定义的生物标志物组方面与面对面听觉词语学习测试具有相似的能力。
J Int Neuropsychol Soc. 2024 Feb;30(2):138-151. doi: 10.1017/S1355617723000322. Epub 2023 Jun 30.
3

本文引用的文献

1
First Tau PET Tracer Approved: Toward Accurate In Vivo Diagnosis of Alzheimer Disease.首款tau蛋白正电子发射断层显像(PET)示踪剂获批:迈向阿尔茨海默病的准确活体诊断
J Nucl Med. 2020 Oct;61(10):1409-1410. doi: 10.2967/jnumed.120.252411.
2
Tau-positron emission tomography correlates with neuropathology findings.tau 正电子发射断层扫描与神经病理学发现相关。
Alzheimers Dement. 2020 Mar;16(3):561-571. doi: 10.1016/j.jalz.2019.09.079. Epub 2020 Jan 4.
3
Test-retest repeatability of [F]Flortaucipir PET in Alzheimer's disease and cognitively normal individuals.
Optimum Differentiation of Frontotemporal Lobar Degeneration from Alzheimer Disease Achieved with Cross-Sectional Tau Positron Emission Tomography.
通过横断面 Tau 正电子发射断层扫描实现额颞叶痴呆与阿尔茨海默病的最佳鉴别。
Ann Neurol. 2022 Dec;92(6):1016-1029. doi: 10.1002/ana.26479. Epub 2022 Aug 29.
阿尔茨海默病患者和认知正常个体中[F]Flortaucipir PET 的重测重复性。
J Cereb Blood Flow Metab. 2020 Dec;40(12):2464-2474. doi: 10.1177/0271678X19879226. Epub 2019 Oct 1.
4
A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer's disease dementia.多中心纵向研究氟替卡滨(18F)在正常衰老、轻度认知障碍和阿尔茨海默病痴呆中的作用。
Brain. 2019 Jun 1;142(6):1723-1735. doi: 10.1093/brain/awz090.
5
Progressive Tau Accumulation in Alzheimer Disease: 2-Year Follow-up Study.阿尔茨海默病中 Tau 蛋白的进行性积累:2 年随访研究。
J Nucl Med. 2019 Nov;60(11):1611-1621. doi: 10.2967/jnumed.118.221697. Epub 2019 Mar 29.
6
Predicting diagnosis and cognition with F-AV-1451 tau PET and structural MRI in Alzheimer's disease.使用 F-AV-1451 tau PET 和结构 MRI 预测阿尔茨海默病的诊断和认知。
Alzheimers Dement. 2019 Apr;15(4):570-580. doi: 10.1016/j.jalz.2018.12.001. Epub 2019 Jan 25.
7
Associations between tau, Aβ, and cortical thickness with cognition in Alzheimer disease.阿尔茨海默病患者 Tau、Aβ 与皮质厚度和认知的相关性。
Neurology. 2019 Feb 5;92(6):e601-e612. doi: 10.1212/WNL.0000000000006875. Epub 2019 Jan 9.
8
A Comparison of Partial Volume Correction Techniques for Measuring Change in Serial Amyloid PET SUVR.用于测量淀粉样 PET SUVR 系列变化的部分容积校正技术比较。
J Alzheimers Dis. 2019;67(1):181-195. doi: 10.3233/JAD-180749.
9
Longitudinal tau PET in ageing and Alzheimer's disease.tau 蛋白 PET 成像在衰老和阿尔茨海默病中的应用
Brain. 2018 May 1;141(5):1517-1528. doi: 10.1093/brain/awy059.
10
Test-Retest Reproducibility for the Tau PET Imaging Agent Flortaucipir F 18.Flortaucipir F 18 Tau PET 显像剂的测试-重测可重复性。
J Nucl Med. 2018 Jun;59(6):937-943. doi: 10.2967/jnumed.117.200691. Epub 2017 Dec 28.